Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

Short summary

Whole-genome sequencing of eight AML patients before and after relapse shows the founding clone survives chemotherapy, leading to two relapse patterns: expansion of the founding clone with new mutations, or expansion of a surviving subclone with new mutations.

AI-generated from the title and abstract; the full text is not read.